Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct;21(10):e70734.
doi: 10.1002/alz.70734.

Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers

Affiliations
Review

Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers

D Luke Fischer et al. Alzheimers Dement. 2025 Oct.

Abstract

Our understanding of Alzheimer's disease (AD) and related dementias (ADRD) has grown exponentially, thanks to significant investments by the National Institute on Aging (NIA). This article celebrates the 40th anniversary of the NIA's Alzheimer's Disease Research Centers, highlighting the pivotal role of neuropathology as the bedrock for neurodegeneration research. Neuropathology has championed the key principles of proteinopathy, selective vulnerability, and stereotypic spread. Furthermore, neuropathologic studies advanced our understanding of ADRD prevalence, heterogeneity, clinical-pathological correlations, and genetic underpinnings, spurring biomarker development for target engagement and disease monitoring. Disease-modifying therapies for AD were inspired and informed by neuropathology. The neuropathology community is poised to refine diagnostics, leveraging digital pathology and integrating genetics and pathomics to enhance subtyping for novel precision medicine approaches. Despite some common misconceptions and logistical challenges, neuropathology continues to be a critical component of the ADRD research infrastructure, serving as a key bridge between allied basic and clinical sciences. HIGHLIGHTS: We celebrate 40 years of NIA-funded ADRCs and their contributions through neuropathology studies that have significantly advanced our understanding and treatment of ADRD. Neuropathology uncovers principles of neurodegenerative disease: proteinopathy, selective vulnerability, and stereotypic spread, informing diagnostics and therapies. Development of AD biomarkers with reference to neuropathology enhances accuracy in diagnosis and monitoring, paving the way for targeted disease-modifying therapies. Integration of digital pathology, genetics, and novel tools in neurodegeneration research promises advanced precision medicine approaches and refined diagnostics. Misconceptions and logistical challenges to neuropathological research are addressed to improve understanding and collaboration.

Keywords: Alzheimer disease; dementia; neurodegenerative diseases; neuropathology; pathomics.

PubMed Disclaimer

Conflict of interest statement

D.L.F. has received authorship payment from MedLink, LLC and an honorarium from Topline Bio. K.M. has received consulting fees from Spear Bio. E.B.L. has received consulting fees from Eli Lilly and Wavebreak Therapeutics. Other author disclosures are available in the Supporting Information.

Figures

FIGURE 1
FIGURE 1
NACC neuropathology data since inception. The number of participants in the NACC dataset with neuropathology forms was queried as of June 2025 data freeze and plotted since NACC's inception (analysis using R and graphed with Prism) through only 2023, due to the delay from the time required to process tissue, analyze results, and submit data to the NACC. The number of autopsies performed at ADRCs has remained relatively constant over two decades, maintaining linear growth of the total number of cases over time. NACC, National Alzheimer's Coordinating Center.

References

    1. Beach TG. A history of senile plaques: from Alzheimer to amyloid imaging. J Neuropathol Exp Neurol. 2022;81:387‐413. - PMC - PubMed
    1. Goedert M. Oskar Fischer and the study of dementia. Brain. 2009;132:1102‐1111. - PMC - PubMed
    1. Katzman R. Editorial: the prevalence and malignancy of Alzheimer disease. a major killer. Arch Neurol. 1976;33:217‐218. - PubMed
    1. Brion J‐P, Passareiro H, Nunez J, Flament‐Durand J. Immunological demonstration of tau protein into neurofibrillary tangles of Alzheimer's disease. Arch Biol (Bruxelles). 1985;95:229‐235.
    1. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA. 1975;72:1858‐1862. - PMC - PubMed

Grants and funding

LinkOut - more resources